Koers Omni Bio Pharmaceutical Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 10,89 mln. 10,18 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -7 mln. -6,54 mln. | Nettowinst (verlies) 2014 | -2 mln. -1,87 mln. | EV/omzet 2013 | - |
Nettoschuld 2013 | 441K 412K | Nettoschuld 2014 | 752K 703K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-1,5
x | K/w-verhouding 2014 |
-4,18
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,42% | 122 mld. | |
+19,68% | 115 mld. | |
+21,22% | 26,64 mld. | |
-23,67% | 19,91 mld. | |
-17,47% | 16,32 mld. | |
-45,95% | 15,52 mld. | |
-18,37% | 15,49 mld. | |
+62,49% | 14,83 mld. | |
+2,06% | 13,67 mld. |